85.82

2.23% -1.96

After Hours: 85.83 0.01 +0.01%

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $85.82, with a volume of 752.51K. It is down -2.23% in the last 24 hours and up +12.77% over the past month. Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Previous Close:

$87.78

Open:

$87.8

24h Volume:

752.51K

Relative Volume:

0.82

Market Cap:

$5.59B

Revenue:

$1.54B

Net Income/Loss:

$233.56M

P/E Ratio:

25.49

EPS:

3.3669

Net Cash Flow:

$348.64M

1W Performance:

+2.72%

1M Performance:

+12.77%

6M Performance:

+49.96%

1Y Performance:

-20.52%

1-Day Range:

$85.23

$87.81

1-Week Range:

$80.00

$88.06

52-Week Range:

$47.25

$108.91

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1106)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

1,193

Twitter

Next Earnings Date

2026-05-07

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH vs TAK, ZTS, TEVA, HLN, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH Lantheus Holdings Inc	85.82	5.71B	1.54B	233.56M	348.64M	3.3669
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Upgrade	William Blair	Mkt Perform → Outperform
Dec-12-25	Upgrade	Truist	Hold → Buy
Oct-08-25	Downgrade	Goldman	Buy → Neutral
Aug-12-25	Downgrade	Truist	Buy → Hold
Dec-18-24	Initiated	Goldman	Buy
Sep-03-24	Initiated	Redburn Atlantic	Buy
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

May 05, 2026

Lantheus Holdings Q1 2026 Earnings Preview — May 7, Street Expects $1.23 EPS - AlphaStreet

May 05, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

Lantheus Governance Shifts And Incentives Underpin Recent Share Price Momentum - Sahm

May 04, 2026

May 03, 2026

Kornitzer Capital Management Inc. KS Sells 38,935 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat

May 03, 2026

Behavioral Patterns of LNTH and Institutional Flows - Stock Traders Daily

May 03, 2026

May 02, 2026

Lantheus Holdings, Inc. 8-K Filing: Board Declassification, 2026 Equity Incentive Plan, and Executive Compensation Approval - Minichart

May 02, 2026

Keybank National Association OH Has $2.90 Million Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat

May 02, 2026

May 01, 2026

B. Riley Securities Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $97 - Moomoo

May 01, 2026

Lantheus (NASDAQ: LNTH) declassifies board and expands 2026 equity plan - Stock Titan

May 01, 2026

Apr 30, 2026

Vanguard Capital Management (LNTH) reports 3.42M-share stake (5.25%) - Stock Titan

Apr 30, 2026

Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat

Apr 30, 2026

LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill

Apr 30, 2026

Apr 29, 2026

Lantheus says FDA pushed deadline for reviewing its tumor diagnostic kit application - MSN

Apr 29, 2026

Apr 28, 2026

Sit Small Cap Growth Fund's Lantheus Holdings Inc(LNTH) Holding History - GuruFocus

Apr 28, 2026

Apr 27, 2026

Lantheus Holdings hits 80-plus relative strength rating benchmark - MSN

Apr 27, 2026

Lantheus narrows 2025 revenue outlook to $1.49B-$1.51B and signals leadership transition amid PSMA PET franchise focus - MSN

Apr 27, 2026